This discrepancy just isn't shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, which have similar or better potencies than copyright as dopamine reuptake inhibitors. These findings have evoked a hypothesis that copyright may additionally functionality to be a so-called "DAT inverse agonist" or "destr